SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.

Apple has just released public beta 3 for iPadOS 26.5, watchOS 26.5, and more. Here’s what to expect from this latest beta ...

We gather data from the best available sources, including vendor and retailer listings as well as other relevant and ...

Years of user feedback have led to the new Framework Laptop 13 Pro, an ultraportable device that's both modular and premium.

So when it comes to models that the general public can access, GPT-5.5 has retaken the crown for OpenAI, achieving the ...

Early positioning before institutional capital returns has historically created the biggest gains in crypto cycles, and 2026 ...

Last week, Anthropic announced Project Glasswing, an AI model so effective at discovering software vulnerabilities that they ...

Plus: Spy firms tap into a global telecom weakness to track targets, 500,000 UK health records go up for sale on Alibaba, ...

DDC Enterprise Limited (NYSEAM: DDC) (“DDC,” or the “Company”), a leading multi-brand Asian consumer food company with a growing strategic bitcoin treasury, today issued a corporate update in a Letter ...

After prevailing in two kidney cancer trials in the refractory and early-stage settings, Merck & Co.’s blockbuster prospect ...

Mythos combined four separate low-severity bugs into a complete browser sandbox escape. Traditional scanners evaluate ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated Phase 1 (RMC-9805-001) ...